Clinical Trial Update: A Clinical Study to Evaluate the Efficacy and Safety of D-2570 in the Treatment of Moderate to Severe Plaque Psoriasis. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of D-2570 for moderate to severe plaque psoriasis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• D-2570

Snippet

Sponsor: InventisBio Co., Ltd | Conditions: Plaque Psoriasis | Phase 3 | Status: RECRUITING